Dr. Jamshed Maddahi, MD.
Health Sciences Clinical Professor, Molecular and Medical Pharmacology, UCLA, Los Angeles, CA, USA.
Prof. Jamshed Maddahi is renowned cardiologist with subspecialty interest in nuclear Cardiology. He is a fellow of American College of Cardiology. He has played an important role in developing nuclear cardiology from the days of planar imaging to Cardiac PET and quantitation. He has closely worked with trials evaluating F-18 labeled Flurpridaz as a CAD marker. He has published over 150 papers, book chapters and reviews. He is on several national and international committees and panels guiding nuclear cardiology practice.
Dr. Maddahi will talk on: “Clinical applications of myocardial blood flow measurement by PET” instead of “Cardiac PET”, “Multimodality assessment of myocardial viability; PET,SPECT, MRI” instead of PET/MP, “Future of PET MPI: F-18 Flurpiridaz and other tracers” instead of “MPI PSECT)".
